DSGN designtx.com: Sof marja

designtx.com (DSGN) - korporativ logo

Design Therapeutics (DSGN) uchun sof marja dinamikasi uning dori vositalarining biologik samaradorligi ta'sirini namoyish etadi, bu esa bozor sikllaridan mustaqil qolmoqda. 0.00 tor doiradagi ishlanmalar portfeli bilan bog'liq binary xatarlarni hisobga olgan holda, so'nggi baholash metrikasini belgilaydi. Barqarorlik bioetik standartlarning joriy etilishi va chiqindilarni yo'q qilishga bo'lgan ekologik yondashuv orqali ta'minlanadi, bu esa innovatsion DNA mahsulotlarini yaratish jarayonida laboratoriyalarning uglerod izini minimallashtiradi.

designtx.com (DSGN) - Sof marja 04.07.2022dan 19.11.2026gacha

Design Pharma - tahliliy kesimlar va asosiy koʻrsatkichlar (DSGN)

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Design Therapeutics Inc - DSGN
Design Therapeutics Inc tayyor mahsulotlari

Sof foyda marjasi jami daromadning yakuniy foyda ulushini o'lchaydi, bu esa xarajatlarni boshqarish samaradorligini va biznesning fundamental barqarorligini baholash imkonini beradi. Design Therapeutics (DSGN) kompaniyasining tijorat foyda marjasi tahlili sanoat standartlaridan chetga chiqishlarni ko'rsatadi, bu esa RNA tadqiqotlari va grant moliyalashtirishga e'tibor qaratgan Design Therapeutics (DSGN) kompaniyasining dastlabki bosqichi uchun tashqi M&A yordamsiz operatsion samaradorlikning ko'rsatkichi bo'lib xizmat qiladi.

Asosiy raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX